AFP and hepatocellular carcinoma: For advanced HCC, the rate was 25%.3 The practice guidelines of the American Association for the Study of Liver Diseases have excluded AFP as a diagnostic marker for HCC, and support for this change has been confirmed in other related studies.4,5 In addition, pathological tests are invasive and can lead to complications such as bile leaks, bleeding, and infection.